Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV Infected”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00001119
What this trial is testing

Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 288
Post-approval studies (Phase 4)Study completedNCT01026454
What this trial is testing

Valacyclovir vs. Acyclovir as HSV-2 Suppressive Therapy: Effect on Plasma HIV-1 Levels Among HIV-1/HSV-2 Co-infected Persons

Who this might be right for
HSV InfectionHIV Infection
University of Washington 32
Early research (Phase 1)UnknownNCT03588715
What this trial is testing

Peg-Interferon Alpha 2b Combined With Two Intravenous Broadly HIV-1 Neutralizing Antibodies 3BNC117 and 10-1074 (BEAT-2)

Who this might be right for
HIVHIV/AIDSHIV-1 Infection
Luis Montaner 15
Not applicableStudy completedNCT00002048
What this trial is testing

The Efficacy and Safety of Retrovir in Patients Infected With HIV Who Are Asymptomatic (CDC Group II) or Have Persistent Generalized Lymphadenopathy (CDC Group III)

Who this might be right for
Lymphatic DiseaseHIV Infections
Glaxo Wellcome
Not applicableUnknownNCT05085158
What this trial is testing

Pathogen Detection in HIV-infected Children With Non-malarial Febrile Illnesses Using Metagenomic Sequencing

Who this might be right for
HIV Infection
Makerere University 138
Not applicableUnknownNCT00331448
What this trial is testing

Observational Study of Changes in Fat Distribution and Blood Metabolites in HIV Infected Adults

Who this might be right for
HIV InfectionsLipodystrophyDiabetes+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 1,483
Not applicableStudy completedNCT05458752
What this trial is testing

Pneumocystis Jirovecii Pneumonia in Non-HIV-infected Immunocompromised Patients

Who this might be right for
Pneumocystis Jirovecii Infection
Central Hospital, Nancy, France 133
Not applicableStudy completedNCT01815255
What this trial is testing

TDF Long Term Study

Who this might be right for
HIV-infected Thai Children
The HIV Netherlands Australia Thailand Research Collaboration 36
Not applicableStudy completedNCT01252537
What this trial is testing

Immunosuppression in HIV-infected Patients With Tuberculosis in Ethiopia

Who this might be right for
HIV InfectionTuberculosisImmunosuppression
Lund University 1,200
Not applicableEnded earlyNCT00937729
What this trial is testing

Prospective Evaluation Among Patients Infected by HIV 1 in Virological Failure Owing to Lack of Compliance, of the Benefit in Terms of Compliance of an Optimised Antiretroviral Treatment With Enfuvirtide (Fuzeon) Associated With Two Active Molecules

Who this might be right for
HIV1 InfectionHIV Infections
University Hospital, Rouen 4
Not applicableStudy completedNCT00014937
What this trial is testing

Simplified Drug Regimens for HIV Patients in ACTG 388 or Patients Who Responded to A First Potent Combination Regimen

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 240
Not applicableStudy completedNCT02925429
What this trial is testing

PostNAPS: FI, Nutrition, and Psychosocial Health Among Women of Mixed HIV Status and Their Infants in Gulu, Uganda

Who this might be right for
Food InsecurityHIVMaternal and Child Health+2 more
Northwestern University 246
Large-scale testing (Phase 3)Study completedNCT00001022
What this trial is testing

A Comparison of Zidovudine (AZT) Used Alone or in Combination With Didanosine (ddI) or Dideoxycytidine (ddC) in HIV-Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 1,200
Early research (Phase 1)Ended earlyNCT02531295
What this trial is testing

Immunologic Response to Kansui in Treated HIV+ Individuals: a Dose Escalation Study

Who this might be right for
HIVHuman Immunodeficiency Virus
University of California, San Francisco 5
Testing effectiveness (Phase 2)Study completedNCT00002079
What this trial is testing

Phase II Study of the Safety and Surrogate Marker Efficacy of Butyldeoxynojirimycin (SC-48334) and AZT in Symptomatic HIV-1 Infected Patients With 200 - 500 CD4+ Cells/mm3. (NOTE: Asymptomatic HIV-1 Infected Patients Also Eligible)

Who this might be right for
HIV Infections
G D Searle
Post-approval studies (Phase 4)Study completedNCT00976040
What this trial is testing

Optimal Time to Start Antiretroviral Therapy in HIV-infected Adults With Cryptococcal Meningitis

Who this might be right for
Cryptococcal MeningitisHIV Infections
Botswana-UPenn Partnership 28
Testing effectiveness (Phase 2)Study completedNCT00071890
What this trial is testing

Phase II/III Study Evaluating the Effect of IL-2 on Preservation of the CD4 T-Lymphocytes After Interruption of Antiretroviral Treatment in HIV-Infected Patients With CD4 T-Lymphocyte Count Greater Than 500 Cells/mm3 Who Received Antiretroviral Tx

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 148
Large-scale testing (Phase 3)Study completedNCT00450580
What this trial is testing

HIV-1 Infection Study of Once a Day Versus Twice a Day Protease Inhibitor in Antiretroviral Treatment Naive Adults

Who this might be right for
Infection, Human Immunodeficiency Virus IHIV-1 Infection
ViiV Healthcare 212
Testing effectiveness (Phase 2)WithdrawnNCT00614640
What this trial is testing

Safety and Tolerability of a Therapeutic DNA Dendritic Cell Vaccine in HIV-Infected Children, Adolescents, and Young Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Large-scale testing (Phase 3)Study completedNCT02422797
What this trial is testing

Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-2)

Who this might be right for
HIV Infections
ViiV Healthcare 518
Next Page